Osmotic Laxative Therapy Guidelines

Primary Indications for Osmotic Laxatives

The American College of Physicians recommends using osmotic laxatives as first-line pharmacological therapy for constipation in patients, especially the elderly, those with limited mobility, or those on opioid therapy 1, 2.
Osmotic laxatives, such as polyethylene glycol (PEG), lactulose, or magnesium/sulfate salts, are preferred first-line agents when non-pharmacological measures are insufficient or impractical 1, 2, 5, 6.

The European Society of Clinical Nutrition and Metabolism suggests that PEG 17 g/day offers the most efficacious and tolerable solution for elderly patients with an excellent safety profile 7, 1, 5.
Osmotic laxatives are particularly suitable for elderly patients because bulk-forming laxatives require increased fluid intake, which is often impractical in frail elderly patients with limited mobility or decreased oral intake 7, 1.

The American Gastroenterological Association recommends PEG 17 g/day as the preferred osmotic laxative for elderly patients and long-term use due to superior safety and efficacy data 7, 1, 5, 3, 4.
Magnesium-containing osmotic laxatives should be used with extreme caution in elderly patients due to the risk of hypermagnesemia, particularly in those with renal impairment 1, 2, 5, 6, 3, 4.

The National Institute for Health and Care Excellence suggests starting PEG 17 g/day as the first-line osmotic laxative for most patients, particularly the elderly 7, 1, 5, 3, 4.
For opioid-induced constipation, initiate an osmotic laxative prophylactically at opioid initiation 1, 2, 6, 4.

The American Heart Association recommends regular monitoring for patients with chronic kidney or heart failure when osmotic laxatives are used concomitantly with diuretics or cardiac glycosides due to the risk of dehydration and electrolyte imbalances 7, 1, 5, 3, 4.
Do not use bulk-forming laxatives in non-ambulatory patients with low fluid intake or in opioid-induced constipation 7, 1, 2, 6, 3.
Avoid magnesium-based osmotic laxatives in elderly patients with renal impairment without close monitoring 1, 2, 5, 6, 3, 4.